NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDPeginterferon Alfa-2a 90mcg, 135mcg, 180mcg Pegasys®
(Pre-filled syringe) 		Malignant disease and immunosuppression, Interferon Alfa, 08.02.04
REDPeginterferon beta-1a Plegridy®
(Pre-filled pen) 		Malignant disease and immunosuppression, Interferon Alfa, 08.02.04
REDSimeprevir 150mg Olysio®
(Capsules) 		Infections, Chronic hepatitis C, 05.03.03.02
REDSofosbuvir 400mg Sovaldi®
(Tablets) 		Infections, Chronic hepatitis C, 05.03.03.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Peginterferon  Peginterferon Alfa Anti-Infective, Immunostimulants, Interferons
Viral Infection, Hepatitis Infections, Chronic Hepatitis B
Peginterferon  Peginterferon Alfa Anti-Infective, Immunostimulants, Interferons
Viral Infection, Hepatitis Infections, Chronic Hepatitis C
Peginterferon  Peginterferon Beta-1A Immune System, Immunostimulants, Interferons
Immune System Disorders And Transplantation, Multiple Sclerosis
Ropeginterferon Ropeginterferon Alfa-2B [Specialist Drug] Malignant Disease, Immunostimulants, Interferons
Cytotoxic Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA 624 Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
NICE TA106: Hepatitis C - peginterferon alfa and ribavirin
NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
NICE TA200: Hepatitis C - peginterferon alfa and ribavirin
NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
NICE TA300: Hepatitis C (children and young people) - peginterferon alfa and ribavirin
NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
NICE TA331: Simeprevir in combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C